$83.93
4.095.12%
In chiusura: Nov 21, 4:00 PM EST
$83.93
N/A
After hour: 4:01 PM EST
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Inhibrx Biosciences Inc (NASDAQ:INBX) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 532.66K a 1.03M. Questo rappresenta il 9.76% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 1.03M azioni scambiate al giorno, ci vorrebbero 1 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
1.03M
Vendite allo scoperto %
9.76%
Giorni di copertura
1
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
INBX | Inhibrx Biosciences, Inc. Comm | 10/31/2025 | 11/11/2025 | 9.76% | 10,508,250 | 1,026,055 | 1,026,597 | 1 | |
INBX | Inhibrx Biosciences, Inc. Comm | 10/15/2025 | 10/24/2025 | 5.07% | 10,508,250 | 532,661 | 161,268 | 3.3 | |
INBX | Inhibrx Biosciences, Inc. Comm | 09/30/2025 | 10/09/2025 | 4.99% | 10,508,250 | 524,531 | 149,004 | 3.52 | |
INBX | Inhibrx Biosciences, Inc. Comm | 09/15/2025 | 09/24/2025 | 6.87% | 10,508,250 | 721,500 | 95,876 | 7.53 | |
INBX | Inhibrx Biosciences, Inc. Comm | 08/29/2025 | 09/10/2025 | 7.54% | 10,508,250 | 792,236 | 125,181 | 6.33 | |
INBX | Inhibrx Biosciences, Inc. Comm | 08/15/2025 | 08/26/2025 | 7.12% | 10,508,250 | 748,150 | 85,060 | 8.8 | |
INBX | Inhibrx Biosciences, Inc. Comm | 07/31/2025 | 08/11/2025 | 6.45% | 10,498,733 | 676,803 | 119,568 | 5.66 | |
INBX | Inhibrx Biosciences, Inc. Comm | 07/15/2025 | 07/24/2025 | 8.56% | 10,498,733 | 898,441 | 163,482 | 5.5 | |
INBX | Inhibrx Biosciences, Inc. Comm | 06/30/2025 | 07/10/2025 | 6.77% | 10,498,733 | 710,674 | 95,526 | 7.44 | |
INBX | Inhibrx Biosciences, Inc. Comm | 06/13/2025 | 06/25/2025 | 7.45% | 10,498,733 | 782,491 | 67,019 | 11.68 | |
INBX | Inhibrx Biosciences, Inc. Comm | 05/30/2025 | 06/10/2025 | 6.73% | 10,498,733 | 706,979 | 98,300 | 7.19 | |
INBX | Inhibrx Biosciences, Inc. Comm | 05/15/2025 | 05/27/2025 | 7.20% | 10,498,733 | 756,289 | 101,861 | 7.42 | |
INBX | Inhibrx Biosciences, Inc. Comm | 04/30/2025 | 05/09/2025 | 6.95% | 10,498,733 | 729,920 | 87,425 | 8.35 | |
INBX | Inhibrx Biosciences, Inc. Comm | 04/15/2025 | 04/25/2025 | 7.21% | 10,498,733 | 757,291 | 183,809 | 4.12 | |
INBX | Inhibrx Biosciences, Inc. Comm | 03/31/2025 | 04/09/2025 | — | — | 934,225 | 80,702 | 11.58 | |
INBX | Inhibrx Biosciences, Inc. Comm | 03/14/2025 | 03/25/2025 | — | — | 955,403 | 120,146 | 7.95 | |
INBX | Inhibrx Biosciences, Inc. Comm | 02/28/2025 | 03/11/2025 | — | — | 1,186,159 | 74,889 | 15.84 | |
INBX | Inhibrx Biosciences, Inc. Comm | 02/14/2025 | 02/26/2025 | — | — | 1,278,420 | 73,119 | 17.48 | |
INBX | Inhibrx Biosciences, Inc. Comm | 01/31/2025 | 02/11/2025 | — | — | 1,221,041 | 113,246 | 10.78 | |
INBX | Inhibrx Biosciences, Inc. Comm | 01/15/2025 | 01/27/2025 | — | — | 1,287,370 | 79,902 | 16.11 | |
INBX | Inhibrx Biosciences, Inc. Comm | 12/31/2024 | 01/10/2025 | — | — | 1,245,172 | 77,342 | 16.1 | |
INBX | Inhibrx Biosciences, Inc. Comm | 12/13/2024 | 12/24/2024 | — | — | 1,204,251 | 73,703 | 16.34 | |
INBX | Inhibrx Biosciences, Inc. Comm | 11/29/2024 | 12/10/2024 | — | — | 1,089,621 | 77,717 | 14.02 | |
INBX | Inhibrx Biosciences, Inc. Comm | 11/15/2024 | 11/26/2024 | — | — | 1,028,479 | 77,633 | 13.25 | |
INBX | Inhibrx Biosciences, Inc. Comm | 10/31/2024 | 11/11/2024 | — | — | 976,671 | 41,812 | 23.36 | |
INBX | Inhibrx Biosciences, Inc. Comm | 10/15/2024 | 10/24/2024 | — | — | 895,657 | 93,233 | 9.61 | |
INBX | Inhibrx Biosciences, Inc. Comm | 09/30/2024 | 10/09/2024 | — | — | 742,518 | 116,353 | 6.38 | |
INBX | Inhibrx Biosciences, Inc. Comm | 09/13/2024 | 09/24/2024 | — | — | 677,716 | 137,285 | 4.94 | |
INBX | Inhibrx Biosciences, Inc. Comm | 08/30/2024 | 09/11/2024 | — | — | 700,661 | 91,913 | 7.62 | |
INBX | Inhibrx Biosciences, Inc. Comm | 08/15/2024 | 08/26/2024 | — | — | 752,846 | 91,475 | 8.23 | |
INBX | Inhibrx Biosciences, Inc. Comm | 07/31/2024 | 08/09/2024 | — | — | 710,371 | 93,664 | 7.58 | |
INBX | Inhibrx Biosciences, Inc. Comm | 07/15/2024 | 07/24/2024 | — | — | 732,578 | 142,260 | 5.15 | |
INBX | Inhibrx Biosciences, Inc. Comm | 06/28/2024 | 07/10/2024 | — | — | 570,380 | 330,361 | 1.73 | |
INBX | Inhibrx Biosciences, Inc. Comm | 06/14/2024 | 06/26/2024 | — | — | 884,068 | 372,941 | 2.37 | |
INBX | Inhibrx Biosciences, Inc. Comm | 05/31/2024 | 06/11/2024 | — | — | 1,300,028 | 135,248 | 9.61 | |
INBX | Inhibrx, Inc. Common Stock | 05/15/2024 | 05/24/2024 | 5.71% | 35,977,350 | 2,052,942 | 638,121 | 3.22 | |
INBX | Inhibrx, Inc. Common Stock | 04/30/2024 | 05/09/2024 | 6.10% | 35,977,350 | 2,194,181 | 284,187 | 7.72 | |
INBX | Inhibrx, Inc. Common Stock | 04/15/2024 | 04/24/2024 | 7.11% | 30,967,856 | 2,200,499 | 466,268 | 4.72 | |
INBX | Inhibrx, Inc. Common Stock | 03/28/2024 | 04/09/2024 | 6.95% | 30,967,856 | 2,152,176 | 355,755 | 6.05 | |
INBX | Inhibrx, Inc. Common Stock | 03/15/2024 | 03/26/2024 | 5.17% | 30,967,856 | 1,599,883 | 759,249 | 2.11 | |
INBX | Inhibrx, Inc. Common Stock | 02/29/2024 | 03/11/2024 | 6.29% | 30,967,856 | 1,946,546 | 449,693 | 4.33 | |
INBX | Inhibrx, Inc. Common Stock | 02/15/2024 | 02/27/2024 | 6.68% | 31,465,097 | 2,103,038 | 391,500 | 5.37 | |
INBX | Inhibrx, Inc. Common Stock | 01/31/2024 | 02/09/2024 | 7.64% | 31,465,097 | 2,404,719 | 1,611,494 | 1.49 | |
INBX | Inhibrx, Inc. Common Stock | 01/12/2024 | 01/24/2024 | 12.99% | 31,465,097 | 4,086,278 | 651,199 | 6.28 | |
INBX | Inhibrx, Inc. Common Stock | 12/29/2023 | 01/10/2024 | 10.83% | 31,377,702 | 3,399,089 | 563,274 | 6.03 | |
INBX | Inhibrx, Inc. Common Stock | 12/15/2023 | 12/27/2023 | 11.54% | 31,377,702 | 3,621,755 | 531,027 | 6.82 | |
INBX | Inhibrx, Inc. Common Stock | 11/30/2023 | 12/11/2023 | 16.51% | 31,377,702 | 5,179,142 | 317,913 | 16.29 | |
INBX | Inhibrx, Inc. Common Stock | 11/15/2023 | 11/27/2023 | 16.86% | 31,377,702 | 5,291,137 | 429,036 | 12.33 |
In cerca di azioni più vendute allo scoperto?